Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 32.82% |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 243.90% |
| Jul 31, 2023 | 120.68% |
| Jan 31, 2023 | 196.63% |
| Oct 31, 2022 | 151.46% |
| Jan 31, 2022 | 27.94% |
| Oct 31, 2021 | 10.46% |
| Apr 30, 2021 | 51.18% |
| Oct 31, 2020 | -21.67% |
| Aug 31, 2018 | -4.34% |
| May 31, 2018 | -24.62% |
| Feb 28, 2018 | 6.37% |
| Nov 30, 2017 | -21.04% |
| Aug 31, 2017 | -79.62% |
| May 31, 2017 | -79.30% |
| Feb 28, 2017 | -50.28% |
| Nov 30, 2016 | 10.52% |
| Aug 31, 2016 | 22.26% |
| May 31, 2016 | -7.63% |
| Feb 29, 2016 | -61.96% |
| Nov 30, 2015 | 460.05% |